Publications

(For a full list see below)

1.
Cossu, A. M. et al. MiR-449a ANTAGONIZES EMT THROUGH IL-6-MEDIATED TRANS- SIGNALING IN LARYNGEAL SQUAMOUS CANCER. Molecular Therapy - Nucleic Acids 102140 (2024) http://doi.org/10.1016/j.omtn.2024.102140. Cite
1.
Petralia, F. et al. Pan-cancer proteogenomics characterization of tumor immunity. Cell S0092867424000643 (2024) http://doi.org/10.1016/j.cell.2024.01.027. Cite Download
1.
Ramsoomair, C. K., Ceccarelli, M., Heiss, J. D. & Shah, A. H. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses. J Transl Med 21, 893 (2023). Cite
1.
Hu, L. S. et al. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. Nat Commun 14, 6066 (2023). Cite Download
1.
Hu, L. S. et al. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. Nat Commun 14, 6066 (2023). Cite
1.
Noviello, T. M. R. et al. Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. Nat Commun 14, 5914 (2023). Cite Download
1.
Mogenet, A. et al. Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer. J Transl Med 21, 637 (2023). Cite Download
1.
Jethalia, M., Jani, S. P., Ceccarelli, M. & Mall, R. Pancancer network analysis reveals key master regulators for cancer invasiveness. J Transl Med 21, 558 (2023). Cite Download
1.
Ferraro, L., Scala, G., Cerulo, L., Carosati, E. & Ceccarelli, M. MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model. Bioinformatics 39, btad432 (2023). Cite Download
1.
Besharat, Z. M. et al. Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients. J Endocrinol Invest (2023) http://doi.org/10.1007/s40618-023-02115-2. Cite
1.
De Falco, A., Caruso, F., Su, X.-D., Iavarone, A. & Ceccarelli, M. A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data. Nature Communications 14, 1074 (2023). Cite Download
1.
Rosaria Noviello, T. M. et al. Guadecitabine plus Ipilimumab in Unresectable Melanoma: Five-Year Follow-up and Correlation with Integrated, Multiomic Analysis in the NIBIT-M4 Trial. http://medrxiv.org/lookup/doi/10.1101/2023.02.09.23285227 (2023) doi:10.1101/2023.02.09.23285227. Cite Download
1.
Migliozzi, S. et al. Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nat Cancer (2023) http://doi.org/10.1038/s43018-022-00510-x. Cite Download
1.
Simeone, I. & Ceccarelli, M. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators. J Transl Med 21, 55 (2023). Cite Download
1.
McLaughlin, R. T. et al. Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning. npj Precis. Onc. 7, 4 (2023). Cite Download
1.
Feng, S. et al. Decomprolute: A Benchmarking Platform Designed for Multiomics-Based Tumor Deconvolution. http://biorxiv.org/lookup/doi/10.1101/2023.01.05.522902 (2023) doi:10.1101/2023.01.05.522902. Cite Download
1.
Wang, J. M. et al. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell Reports Medicine 101173 (2023) http://doi.org/10.1016/j.xcrm.2023.101173. Cite Download
1.
Liang, W.-W. et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell S1535610823002532 (2023) http://doi.org/10.1016/j.ccell.2023.07.013. Cite
1.
Li, Y. et al. Proteogenomic data and resources for pan-cancer analysis. Cancer Cell 41, 1397–1406 (2023). Cite Download
1.
Li, Y. et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell 186, 3921-3944.e25 (2023). Cite Download
1.
Geffen, Y. et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186, 3945-3967.e26 (2023). Cite Download
1.
Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat Med 29, 1273–1286 (2023). Cite Download
1.
Di Giacomo, A. M. et al. Immunotherapy for brain metastases and primary brain tumors. European Journal of Cancer 179, 113–120 (2023). Cite
1.
Mason, M. et al. A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. http://biorxiv.org/lookup/doi/10.1101/2022.12.05.518667 (2022) doi:10.1101/2022.12.05.518667. Cite Download
1.
Anichini, A. et al. Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. Journal of Experimental & Clinical Cancer Research 41, 325 (2022). Cite
1.
Sabato, C. et al. A novel microRNA signature for the detection of melanoma by liquid biopsy. J Transl Med 20, 469 (2022). Cite Download
1.
White, B. S. et al. Community Assessment of Methods to Deconvolve Cellular Composition from Bulk Gene Expression. http://biorxiv.org/lookup/doi/10.1101/2022.06.03.494221 (2022) doi:10.1101/2022.06.03.494221. Cite Download
1.
Federico, A. et al. Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study. Cancers 14, 2043 (2022). Cite Download
1.
Anichini, A. et al. Landscape of Immune-Related Signatures Induced by Targeting of Different Epigenetic Regulators in Melanoma: Implications for Immunotherapy. http://biorxiv.org/lookup/doi/10.1101/2022.04.13.488140 (2022) doi:10.1101/2022.04.13.488140. Cite Download
1.
Chan, S. et al. An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Nat Cancer (2022) http://doi.org/10.1038/s43018-022-00334-9. Cite Download
1.
Simeone, I. et al. Prediction and pan-cancer analysis of mammalian transcripts involved in target directed miRNA degradation. Nucleic Acids Research 50, 2019–2035 (2022). Cite Download
1.
Sayaman, R. W. et al. Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors. STAR Protocols 3, 101809 (2022). Cite
1.
D’Agostino, Y. et al. Loss of circadian rhythmicity in bdnf knock-out zebrafish larvae. iScience 104054 (2022) http://doi.org/10.1016/j.isci.2022.104054. Cite Download
1.
Saad, M. et al. Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study. The Lancet Oncology S147020452100752X (2022) http://doi.org/10.1016/S1470-2045(21)00752-X. Cite
1.
Bertucci, F. et al. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. J Immunother Cancer 10, e003687 (2022). Cite Download
1.
McLaughlin, R. T. et al. Attentive Deep Learning-Based Tumor-Only Somatic Mutation Classifier Achieves High Accuracy Agnostic of Tissue Type and Capture Kit. http://biorxiv.org/lookup/doi/10.1101/2021.12.07.471513 (2021) doi:10.1101/2021.12.07.471513. Cite Download
1.
De Falco, A., Caruso, F. P., Su, X. D., Iavarone, A. & Ceccarelli, M. A Fast Variational Algorithm to Detect the Clonal Copy Number Substructure of Tumors from Single-Cell Data. http://biorxiv.org/lookup/doi/10.1101/2021.11.20.469390 (2021) doi:10.1101/2021.11.20.469390. Cite Download
1.
Petralia, F. et al. BayesDeBulk: A Flexible Bayesian Algorithm for the Deconvolution of Bulk Tumor Data. http://biorxiv.org/lookup/doi/10.1101/2021.06.25.449763 (2021) doi:10.1101/2021.06.25.449763. Cite Download
1.
Mall, R. et al. Network-based identification of key master regulators associated with an immune-silent cancer phenotype. Briefings in Bioinformatics bbab168 (2021) http://doi.org/10.1093/bib/bbab168. Cite Download
1.
Paladino, A., D’Angelo, F., Noviello, T. M. R., Iavarone, A. & Ceccarelli, M. Structural Model for Recruitment of RIT1 to the LZTR1 E3 Ligase: Evidences from an Integrated Computational Approach. J. Chem. Inf. Model. acs.jcim.1c00296 (2021) http://doi.org/10.1021/acs.jcim.1c00296. Cite Download
1.
Caruso, F. P., Scala, G., Cerulo, L. & Ceccarelli, M. A review of COVID-19 biomarkers and drug targets: resources and tools. Briefings in Bioinformatics 22, 701–713 (2021). Cite Download
1.
Petrillo, F. et al. Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus. J Am Soc Nephrol (2021) http://doi.org/10.1681/ASN.2020010031. Cite
1.
Di Munno, C. et al. Adaptive Thermogenesis Driving Catch-Up Fat Is Associated With Increased Muscle Type 3 and Decreased Hepatic Type 1 Iodothyronine Deiodinase Activities: A Functional and Proteomic Study. Front. Endocrinol. 12, 631176 (2021). Cite
1.
De Marco, C. et al. Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer. Translational Oncology 14, 101013 (2021). Cite Download
1.
Turan, T. et al. A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. Br J Cancer 124, 760–769 (2021). Cite Download
1.
Sayaman, R. W. et al. Germline genetic contribution to the immune landscape of cancer. Immunity 54, 367-386.e8 (2021). Cite Download
1.
Litchfield, K. et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell 184, 596-614.e14 (2021). Cite
1.
Garofano, L. et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat Cancer (2021) http://doi.org/10.1038/s43018-020-00159-4. Cite Download
1.
Maio, M. et al. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation. J Exp Clin Cancer Res 40, 240 (2021). Cite Download
1.
Wang, L.-B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell (2021) http://doi.org/10.1016/j.ccell.2021.01.006. Cite Download